Scholar Rock Holding Corporation
NASDAQ:SRRK
44.32 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Scholar Rock Holding Corporation |
Symbool | SRRK |
Munteenheid | USD |
Prijs | 44.32 |
Beurswaarde | 4,149,012,368 |
Dividendpercentage | 0% |
52-weken bereik | 6.76 - 46.185 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jay T. Backstrom M.D., M.P.H. |
Website | https://scholarrock.com |
An error occurred while fetching data.
Over Scholar Rock Holding Corporation
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)